SCHEMBL853436

SCHEMBL853436

CCCCCNc1nc(C)c(Cc2ccc(OCCN3CCCC3)cc2)c(N)n1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 13/20 0.54
LTA4H P09960 6/20 0.50
PSMB1 P20618 1/20 0.46
PSMB5 P28074 1/20 0.46
PSMB2 P49721 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL861355 0.96 TLR7 (0.56) TLR7LTA4H
SCHEMBL861830 0.90 TLR7 (0.60) TLR7
SCHEMBL853780 0.89 DHFR (0.58) TLR7LTA4H
SCHEMBL861371 0.89 DHFR (0.57) TLR7LTA4H
SCHEMBL855086 0.85 DHFR (0.47) TLR7
SCHEMBL3709605 0.85 TLR7 (0.73) TLR7
SCHEMBL3699429 0.84 TLR7 (0.72) TLR7
SCHEMBL853213 0.83 TLR7 (0.57) TLR7
SCHEMBL854804 0.83 TLR7 (0.55) TLR7LTA4H
SCHEMBL3702171 0.81 TLR7 (0.75) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2432768-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES AstraZeneca AB (SE) 2012-03-28 EP disclosed
WO-2010133885-A1 NOVEL PYRIMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CANCER AND FURTHER DISEASES ASTRAZENECA AB (SE) 2010-11-25 WO disclosed